# Buprenorphine and Naloxone

NDC: 60687-626
Generic name: Buprenorphine and Naloxone
Labeler / Manufacturer: American Health Packaging
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: SUBLINGUAL
Marketing started: 20220310

FDA application: ANDA205601

## Active ingredients

- BUPRENORPHINE HYDROCHLORIDE: 2 mg/1
- NALOXONE HYDROCHLORIDE DIHYDRATE: .5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"60687-626"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=60687-626
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b05b0087-c0ef-40be-9bf3-3933f6cd3492